113 related articles for article (PubMed ID: 16880606)
1. Creation of novel Protein Transduction Domain (PTD) mutants by a phage display-based high-throughput screening system.
Mukai Y; Sugita T; Yamato T; Yamanada N; Shibata H; Imai S; Abe Y; Nagano K; Nomura T; Tsutsumi Y; Kamada H; Nakagawa S; Tsunoda S
Biol Pharm Bull; 2006 Aug; 29(8):1570-4. PubMed ID: 16880606
[TBL] [Abstract][Full Text] [Related]
2. Creation of novel cell-penetrating peptides for intracellular drug delivery using systematic phage display technology originated from Tat transduction domain.
Kamada H; Okamoto T; Kawamura M; Shibata H; Abe Y; Ohkawa A; Nomura T; Sato M; Mukai Y; Sugita T; Imai S; Nagano K; Tsutsumi Y; Nakagawa S; Mayumi T; Tsunoda S
Biol Pharm Bull; 2007 Feb; 30(2):218-23. PubMed ID: 17268054
[TBL] [Abstract][Full Text] [Related]
3. Cellular uptake and lysosomal delivery of galactocerebrosidase tagged with the HIV Tat protein transduction domain.
Zhang XY; Dinh A; Cronin J; Li SC; Reiser J
J Neurochem; 2008 Feb; 104(4):1055-64. PubMed ID: 17986221
[TBL] [Abstract][Full Text] [Related]
4. Effects of protein transduction domain (PTD) selection and position for improved intracellular delivery of PTD-Hsp27 fusion protein formulations.
Ul Ain Q; Lee JH; Woo YS; Kim YH
Arch Pharm Res; 2016 Sep; 39(9):1266-74. PubMed ID: 27381220
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo.
Mi Z; Mai J; Lu X; Robbins PD
Mol Ther; 2000 Oct; 2(4):339-47. PubMed ID: 11020349
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.
Kim M; Maeng J; Jung J; Kim HY; Kim HJ; Kwon Y; Lee K
Eur J Pharm Sci; 2011 May; 43(1-2):25-31. PubMed ID: 21440624
[TBL] [Abstract][Full Text] [Related]
7. Creation of a novel cell penetrating peptide, using a random 18mer peptides library.
Nomura T; Kawamura M; Shibata H; Abe Y; Ohkawa A; Mukai Y; Sugita T; Imai S; Nagano K; Okamoto T; Tsutsumi Y; Kamada H; Nakagawa S; Tsunoda S
Pharmazie; 2007 Aug; 62(8):569-73. PubMed ID: 17867548
[TBL] [Abstract][Full Text] [Related]
8. [Protein transduction by poly-arginine].
Matsui H; Tomizawa K; Matsushita M
Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):435-9. PubMed ID: 12835537
[TBL] [Abstract][Full Text] [Related]
9. LBT/PTD dual tagged vector for purification, cellular protein delivery and visualization in living cells.
Goda N; Tenno T; Inomata K; Iwaya N; Sasaki Y; Shirakawa M; Hiroaki H
Biochim Biophys Acta; 2007 Feb; 1773(2):141-6. PubMed ID: 17207544
[TBL] [Abstract][Full Text] [Related]
10. Protein transduction domains fused to virus receptors improve cellular virus uptake and enhance oncolysis by tumor-specific replicating vectors.
Kühnel F; Schulte B; Wirth T; Woller N; Schäfers S; Zender L; Manns M; Kubicka S
J Virol; 2004 Dec; 78(24):13743-54. PubMed ID: 15564483
[TBL] [Abstract][Full Text] [Related]
11. Nanostructured materials designed for cell binding and transduction.
Liu J; Zhang Q; Remsen EE; Wooley KL
Biomacromolecules; 2001; 2(2):362-8. PubMed ID: 11749193
[TBL] [Abstract][Full Text] [Related]
12. Comparison of protein transduction domains in mediating cell delivery of a secreted CRE protein.
Shaw PA; Catchpole IR; Goddard CA; Colledge WH
Biochemistry; 2008 Jan; 47(4):1157-66. PubMed ID: 18179254
[TBL] [Abstract][Full Text] [Related]
13. The augmentation of intracellular delivery of peptide therapeutics by artificial protein transduction domains.
Yoshikawa T; Sugita T; Mukai Y; Abe Y; Nakagawa S; Kamada H; Tsunoda S; Tsutsumi Y
Biomaterials; 2009 Jul; 30(19):3318-23. PubMed ID: 19304319
[TBL] [Abstract][Full Text] [Related]
14. Preparation and functional analysis of recombinant protein transduction domain-metallothionein fusion proteins.
Lim KS; Won YW; Park YS; Kim YH
Biochimie; 2010 Aug; 92(8):964-70. PubMed ID: 20403412
[TBL] [Abstract][Full Text] [Related]
15. The taming of the cell penetrating domain of the HIV Tat: myths and realities.
Chauhan A; Tikoo A; Kapur AK; Singh M
J Control Release; 2007 Feb; 117(2):148-62. PubMed ID: 17196289
[TBL] [Abstract][Full Text] [Related]
16. Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo.
Ho A; Schwarze SR; Mermelstein SJ; Waksman G; Dowdy SF
Cancer Res; 2001 Jan; 61(2):474-7. PubMed ID: 11212234
[TBL] [Abstract][Full Text] [Related]
17. A protein transduction domain with cell uptake and selectivity profiles that are controlled by multivalency effects.
DePorter SM; Lui I; Mohan U; McNaughton BR
Chem Biol; 2013 Mar; 20(3):434-44. PubMed ID: 23521800
[TBL] [Abstract][Full Text] [Related]
18. Intracellular transduction and potential of Tat PTD and its analogs: from basic drug delivery mechanism to application.
Zhang X; Zhang X; Wang F
Expert Opin Drug Deliv; 2012 Apr; 9(4):457-72. PubMed ID: 22432469
[TBL] [Abstract][Full Text] [Related]
19. Transduction of translationally controlled tumor protein employing TCTP-derived protein transduction domain.
Maeng J; Kim HY; Shin DH; Lee K
Anal Biochem; 2013 Apr; 435(1):47-53. PubMed ID: 23256924
[TBL] [Abstract][Full Text] [Related]
20. A peptide carrier for the delivery of biologically active proteins into mammalian cells.
Morris MC; Depollier J; Mery J; Heitz F; Divita G
Nat Biotechnol; 2001 Dec; 19(12):1173-6. PubMed ID: 11731788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
